{"filing":{"accession_number":"0001493152-26-041689","cik":"0001430306","ticker":"TNXP","company_name":"Tonix Pharmaceuticals Holding Corp.","form":"8-K","filing_date":"2026-09-08","report_date":"2026-09-08","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1430306/000149315226041689/form8-k.htm"},"events":[{"id":31774,"run_id":29173,"accession_number":"0001493152-26-041689","anchor_item_number":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the promotion of Thomas Englese to Chief Commercial Officer of Tonix Pharmaceuticals, effective immediately on September 8, 2026. Englese had previously served as Executive Vice President of Commercial Operations since September 2024 and will now lead the company's commercial organization overseeing sales, marketing, and market access for TONMYA and other marketed products. This is a material executive appointment to a C-suite officer role at a commercial-stage biopharmaceutical company.","company_name":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","filing_date":"2026-09-08","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":34756,"accession_number":"0001493152-26-041689","item_number":null,"item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the promotion of Thomas Englese to Chief Commercial Officer of Tonix Pharmaceuticals, effective immediately on September 8, 2026. Englese had previously served as Executive Vice President of Commercial Operations since September 2024 and will now lead the company's commercial organization overseeing sales, marketing, and market access for TONMYA and other marketed products. This is a material executive appointment to a C-suite officer role at a commercial-stage biopharmaceutical company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T11:07:19.302427+00:00","company_name":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","filing_date":"2026-09-08"}]}